Pacira Biosciences, Inc. (PCRX)
22.64
-0.89
(-3.78%)
USD |
NASDAQ |
May 15, 16:00
22.62
-0.02
(-0.07%)
After-Hours: 20:00
Pacira Biosciences Profit Margin (Quarterly) : 1.64% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -18.92% |
| Bristol Myers Squibb Co. | 23.31% |
| Assertio Holdings, Inc. | -189.8% |
| Johnson & Johnson | 21.75% |
| Eli Lilly & Co. | 37.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.71% |
| Return on Assets | 0.37% |
| Return on Invested Capital | 0.42% |
| Gross Profit Margin (Quarterly) | 71.40% |
| Operating Margin (Quarterly) | -0.32% |
| Return on Net Operating Assets | 0.59% |